Conference Correspondent

Conference Correspondent — January 16, 2020
A large observational study showed increased first-line bendamustine-rituximab use among older patients with splenic or nodal marginal zone lymphoma was not associated with significant event-free survival or overall survival benefit versus single-agent rituximab, but led to increased toxicities and costs.
Read Article

Conference Correspondent — January 16, 2020
Updated results from a phase 1/2 trial indicate that acalabrutinib monotherapy was associated with a favorable safety profile and showed antileukemic activity in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma, irrespective of high-risk genomic features.
Read Article

Pharmacy’s Emerging Influence and the Roles Pharmacists Play
Conference Correspondent — October 25, 2019
Leaders in oncology pharmacy tackle some of the biggest issues in the field today in a pre-summit professional development session.
Read Article

Cancer Centers and the Integrated Health Delivery Systems and the Cancer Care Value Perspectives
Conference Correspondent — October 25, 2019
Stakeholders address the challenge of integrating high-cost therapies into cancer care delivery.
Read Article

Insurance Payers and the Cancer Care Value Perspectives
Conference Correspondent — October 25, 2019
Payers identify strategies for promoting value-based, high-quality cancer care.
Read Article

Keynotes Highlight a Successful Summit—Stellar Duo Delivers Outstanding Talks
Conference Correspondent — October 25, 2019
A pair of distinguished keynote speakers gave attendees a rare behind-the-scenes look at healthcare policy decisions at the highest levels.
Read Article

Working with Integrated Health Delivery Systems in Cancer Care Ecosystem
Conference Correspondent — October 25, 2019
The Summit kicked off with opening remarks and the first of the event’s in-depth pre-summit professional development sessions—designed to take a deep dive into select topics.
Read Article

Efforts to Maximize Value-Based Cancer Care in a Fragmented Care Delivery System
Conference Correspondent — December 24, 2018
Despite the fragmented nature of the U.S. care delivery and payment system, disparate healthcare stakeholders continue to seek areas of alignment in reducing inefficiencies and enhancing value-driven oncology care.
Read Article

Quantifying the Impact and Value of Oncology Navigation on Patient Outcomes
Conference Correspondent — December 24, 2018
The development and implementation of validated, evidence-based oncology navigation measures are an integral component of broader efforts to promote patient-centric, value-based cancer care.
Read Article

Value-Based Payment Reform: Focus on the Oncology Care Model
Conference Correspondent — December 24, 2018
The Oncology Care Model was designed to provide higher quality, more highly coordinated oncology care at the same or lower cost to Medicare. As the program matures, new data is expected to provide insight on the achievement of that ambitious goal.
Read Article

Page 11 of 44